Patients are now being recruited for the world’s first personalised genomics-driven ovarian cancer vaccine clinical trial. The goal is to prevent an often deadly relapse of the disease in women diagnosed at advanced stages. The injectable vaccine OncoImmunome works by boosting the patient’s immune response to enable it to destroy ovarian cancer cells should they…